Gene therapy strategies in neurodegenerative diseases.
Identifieur interne : 000204 ( Ncbi/Merge ); précédent : 000203; suivant : 000205Gene therapy strategies in neurodegenerative diseases.
Auteurs : M. Giménez Y Ribotta [France]Source :
- Histology and histopathology [ 0213-3911 ] ; 2001.
English descriptors
- KwdEn :
- Alzheimer Disease (therapy), Amyotrophic Lateral Sclerosis (therapy), Animals, Deafness (therapy), Genetic Therapy (methods), Genetic Vectors, Humans, Huntington Disease (therapy), Neurodegenerative Diseases (therapy), Neurons, Parkinson Disease (therapy), Parkinsonian Disorders (therapy), Promoter Regions, Genetic, Retinitis Pigmentosa (therapy).
- MESH :
Abstract
Treatment of neurodegenerative diseases by classical pharmacotherapy is restricted by blood-brain barrier which prevents access to the brain of potentially therapeutic molecules. Recent progress in the knowledge of pathophysiological molecular processes, and in the development of molecular biotechnology have opened the way to new therapeutic interventions for these disorders. This chapter reviews the most recent gene therapy strategies using experimental models for neurodegenerative diseases.
PubMed: 11510980
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001238
- to stream PubMed, to step Curation: 001197
- to stream PubMed, to step Checkpoint: 001197
Links to Exploration step
pubmed:11510980Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene therapy strategies in neurodegenerative diseases.</title>
<author><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II, France. mgyr@univ-montp2.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II</wicri:regionArea>
<wicri:noRegion>University of Montpellier II</wicri:noRegion>
<wicri:noRegion>University of Montpellier II</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11510980</idno>
<idno type="pmid">11510980</idno>
<idno type="wicri:Area/PubMed/Corpus">001238</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001238</idno>
<idno type="wicri:Area/PubMed/Curation">001197</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001197</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001197</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001197</idno>
<idno type="wicri:Area/Ncbi/Merge">000204</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Gene therapy strategies in neurodegenerative diseases.</title>
<author><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II, France. mgyr@univ-montp2.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II</wicri:regionArea>
<wicri:noRegion>University of Montpellier II</wicri:noRegion>
<wicri:noRegion>University of Montpellier II</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Histology and histopathology</title>
<idno type="ISSN">0213-3911</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (therapy)</term>
<term>Amyotrophic Lateral Sclerosis (therapy)</term>
<term>Animals</term>
<term>Deafness (therapy)</term>
<term>Genetic Therapy (methods)</term>
<term>Genetic Vectors</term>
<term>Humans</term>
<term>Huntington Disease (therapy)</term>
<term>Neurodegenerative Diseases (therapy)</term>
<term>Neurons</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinsonian Disorders (therapy)</term>
<term>Promoter Regions, Genetic</term>
<term>Retinitis Pigmentosa (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Deafness</term>
<term>Huntington Disease</term>
<term>Neurodegenerative Diseases</term>
<term>Parkinson Disease</term>
<term>Parkinsonian Disorders</term>
<term>Retinitis Pigmentosa</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Genetic Vectors</term>
<term>Humans</term>
<term>Neurons</term>
<term>Promoter Regions, Genetic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Treatment of neurodegenerative diseases by classical pharmacotherapy is restricted by blood-brain barrier which prevents access to the brain of potentially therapeutic molecules. Recent progress in the knowledge of pathophysiological molecular processes, and in the development of molecular biotechnology have opened the way to new therapeutic interventions for these disorders. This chapter reviews the most recent gene therapy strategies using experimental models for neurodegenerative diseases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11510980</PMID>
<DateCreated><Year>2001</Year>
<Month>08</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>02</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2012</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0213-3911</ISSN>
<JournalIssue CitedMedium="Print"><Volume>16</Volume>
<Issue>3</Issue>
<PubDate><Year>2001</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Histology and histopathology</Title>
<ISOAbbreviation>Histol. Histopathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Gene therapy strategies in neurodegenerative diseases.</ArticleTitle>
<Pagination><MedlinePgn>883-93</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Treatment of neurodegenerative diseases by classical pharmacotherapy is restricted by blood-brain barrier which prevents access to the brain of potentially therapeutic molecules. Recent progress in the knowledge of pathophysiological molecular processes, and in the development of molecular biotechnology have opened the way to new therapeutic interventions for these disorders. This chapter reviews the most recent gene therapy strategies using experimental models for neurodegenerative diseases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giménez y Ribotta</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II, France. mgyr@univ-montp2.fr</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Histol Histopathol</MedlineTA>
<NlmUniqueID>8609357</NlmUniqueID>
<ISSNLinking>0213-3911</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003638" MajorTopicYN="N">Deafness</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012174" MajorTopicYN="N">Retinitis Pigmentosa</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>100</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year>
<Month>8</Month>
<Day>21</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>2</Month>
<Day>9</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2001</Year>
<Month>8</Month>
<Day>21</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11510980</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000204 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000204 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:11510980 |texte= Gene therapy strategies in neurodegenerative diseases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:11510980" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
This area was generated with Dilib version V0.6.29. |